Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Ragweed (Ambrosia artemisiifolia) is not used in the traditional sense to treat allergic rhinitis; rather, standardized ragweed pollen extracts are employed in allergen immunotherapy (AIT), also known as allergy shots or sublingual tablets, as a scientifically validated approach for treating allergic rhinitis caused by ragweed pollen. The mechanism is based on gradually exposing allergic individuals to controlled doses of the allergen, thereby desensitizing their immune response and reducing symptoms over time.

Numerous randomized controlled trials and meta-analyses support the efficacy of ragweed allergen immunotherapy for reducing symptoms of allergic rhinitis. For example, sublingual ragweed tablets have been shown to significantly decrease symptom severity and medication use in ragweed-allergic patients compared to placebo. The U.S. FDA has approved specific ragweed pollen allergen extracts (e.g., Ragwitek) for this purpose, underscoring regulatory and scientific recognition of its benefit. The safety profile is well-established, with most adverse effects limited to mild local reactions (e.g., oral itching).

It is important to distinguish that while ragweed is the cause of symptoms in allergic rhinitis, its controlled use in immunotherapy is a scientifically validated treatment. This approach is not rooted in traditional medicine but is based on modern immunological principles and rigorous clinical evidence.

More about ragweed
More about Rhinitis, Allergic

Other ingredients used for Rhinitis, Allergic

Other health conditions supported by ragweed

Products containing ragweed